Peritoneal clearances in scleroderma and diabetes mellitus: effects of intraperitioneal isoproterenol
- PMID: 965210
- DOI: 10.1007/BF02082213
Peritoneal clearances in scleroderma and diabetes mellitus: effects of intraperitioneal isoproterenol
Abstract
Reduced peritoneal clearances of creatinine and urate were demonstrated repeatedly in a patient with scleroderma and a patient with diabetes mellitus. Urea clearances were not significantly different from usual values. The findings suggest decreased peritoneal membrane permeability and/or area (if urea clearance is flow limited). Clearances increased to usual values with intraperitioneal isoproterenol in the patient with diabetes. There was no effect of isoproterenol in the patient with scleroderma.
Similar articles
-
Reduced peritoneal clearances in scleroderma increased by intraperitoneal isoproterenol.Ann Intern Med. 1973 Jun;78(6):891-4. doi: 10.7326/0003-4819-78-6-891. Ann Intern Med. 1973. PMID: 4713570 No abstract available.
-
Isoproterenol enhancement of peritoneal permeability.J Dial. 1977;1(4):319-31. doi: 10.3109/08860227709038423. J Dial. 1977. PMID: 608855
-
Transperitoneal solute movement in children.Kidney Int Suppl. 1983 Nov;15:S95-100. Kidney Int Suppl. 1983. PMID: 6584681
-
Influence of intraperitoneal vancomycin on peritoneal dialysis efficiency. A clinical study.Int Urol Nephrol. 1997;29(3):385-9. doi: 10.1007/BF02550940. Int Urol Nephrol. 1997. PMID: 9285315 Clinical Trial.
-
Peritoneal dialysis adequacy: not just small-solute clearance.Adv Perit Dial. 2008;24:99-103. Adv Perit Dial. 2008. PMID: 18986011 Review.